002727.SHE Yunnan Hongxiang Yixintang
- Market cap
- CNY 7.89B
- P/E
- 19.8x
- P/B
- 1.04x
- ROE
- 6.8%
- Dividend yield
- 3.86%
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.
Is 002727.SHE undervalued?
Graham number002727.SHE trades 4.2% below its Graham number.
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Yunnan Hongxiang Yixintang fundamental analysis
No fundamental analysis for Yunnan Hongxiang Yixintang yet.
Yunnan Hongxiang Yixintang stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Yunnan Hongxiang Yixintang
Yixintang Pharmaceutical Group Co., Ltd., together with its subsidiary, engages in the pharmaceutical retail chain and pharmaceutical distribution business. The company is involved in the wholesale, retail, leasing, and operation of medical devices; sale of food, disinfectants, disinfection equipment, and disposable medical products, household appliances, adult toys, agricultural and sideline products, cosmetics, and daily sundries and necessities; manufacturing of glasses; …
Full company profileYunnan Hongxiang Yixintang financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 3 quarters up to Sep 30, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
Yunnan Hongxiang Yixintang annual financial statements (CNY; K = thousand, M = million, B = billion, T = trillion)
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 Anlz |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||||
| Revenue | 6.25B | 7.75B | 9.18B | 10.5B | 12.7B | 14.6B | 17.4B | 17.4B | 18.0B | 17.3B | 16.9B |
| Gross Profit | 2.51B | 3.12B | 3.64B | 3.99B | 4.45B | 5.27B | 5.95B | 5.58B | 5.57B | 5.66B | 5.62B |
| Operating Income | 391M | 507M | 684M | 739M | 918M | 1.07B | 1.24B | 786M | 278M | 745M | 864M |
| EBITDA | 521M | 686M | 820M | 862M | 1.06B | 1.33B | 1.50B | 967M | 468M | 1.79B | 786M |
| Net Income | 353M | 423M | 521M | 604M | 790M | 922M | 1.01B | 549M | 114M | 263M | 508M |
| EPS | 0.68 | 0.81 | 0.92 | 1.06 | 1.38 | 1.56 | 1.70 | 0.92 | 0.19 | 0.45 | 0.87 |
| Balance Sheet | |||||||||||
| Total Assets | 6.01B | 7.15B | 7.36B | 7.96B | 9.33B | 14.3B | 16.2B | 16.6B | 16.8B | 15.6B | 15.5B |
| Total Liabilities | 3.52B | 3.45B | 3.31B | 3.37B | 3.55B | 7.66B | 8.65B | 8.77B | 9.18B | 8.15B | 7.84B |
| Shareholders' Equity | 2.50B | 3.69B | 4.05B | 4.59B | 5.77B | 6.58B | 7.43B | 7.75B | 7.49B | 7.30B | 7.45B |
| Cash & Short-term Investments | 1.59B | 2.20B | 1.35B | 1.46B | 1.62B | 2.53B | 3.52B | 3.90B | 3.42B | 2.30B | 2.85B |
| Total Debt | 795M | 897M | 799M | 483M | 60.1M | 2.91B | 3.09B | 2.02B | 2.03B | - | - |
| Cash Flow | |||||||||||
| Operating Cash Flow | 193M | 391M | 636M | 983M | 1.03B | 1.79B | 2.50B | 2.12B | 1.72B | 1.63B | - |
| Capital Expenditure | 146M | 142M | 156M | 207M | 280M | 392M | 349M | 253M | 255M | 278M | 284M |
| Free Cash Flow | 46.5M | 249M | 480M | 776M | 753M | 1.40B | 2.15B | 1.86B | 1.47B | 1.36B | 2.30B |
| Ratios | |||||||||||
| ROE | 14.2% | 11.4% | 12.9% | 13.1% | 13.7% | 14.0% | 13.6% | 7.1% | 1.5% | 3.6% | 6.8% |
| ROA | 5.9% | 5.9% | 7.1% | 7.6% | 8.5% | 6.4% | 6.2% | 3.3% | 0.7% | 1.7% | 3.3% |
| Net Profit Margin | 5.7% | 5.5% | 5.7% | 5.8% | 6.2% | 6.3% | 5.8% | 3.2% | 0.6% | 1.5% | 3.0% |
| Debt to Equity | 0.32x | 0.24x | 0.20x | 0.11x | 0.01x | 0.44x | 0.42x | 0.26x | 0.27x | - | - |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Total Debt
- Short and long-term borrowings.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
- Debt to Equity
- Total debt divided by shareholders' equity.
Yunnan Hongxiang Yixintang dividends
- Dividend yield
- 3.86%
- Forward dividend
- 0.40 CNY
- Payout ratio
- 115.7%
- Ex-dividend date
- Sep 24, 2026
| Fiscal year | Dividends paid | Per share | Payout ratio |
|---|---|---|---|
| 2025 | CNY 305M | 0.52 | 115.7% |
| 2024 | CNY 261M | 0.44 | 228.3% |
| 2023 | CNY 238M | 0.40 | 43.4% |
| 2022 | CNY 179M | 0.30 | 17.7% |
| 2021 | CNY 179M | 0.30 | 19.4% |
| 2020 | CNY 170M | 0.30 | 21.6% |
| 2019 | CNY 170M | 0.30 | 28.2% |
| 2018 | CNY 212M | 0.37 | 40.6% |
| 2017 | CNY 169M | 0.32 | 39.9% |
From the cash flow statement: dividends paid in the fiscal year, divided by that year's shares outstanding. Payout ratio = dividends paid / net income.
Last stock split: 20:10 on Apr 13, 2016.
Who owns Yunnan Hongxiang Yixintang
- Insiders 48.12%
- Institutions 6.38%
- Public & others 45.50%
- Shares outstanding 586M
- Free float 304M
Yunnan Hongxiang Yixintang company profile
- Company name
- Yunnan Hongxiang Yixintang
- Ticker
- 002727.SHE
- ISIN
- CNE100001WJ8
- Exchange
- Shenzhen Stock Exchange
- Sector
- Healthcare
- Industry
- Consumer Staples Distribution & Retail
- Employees
- 34,848
- Fiscal year end
- December
- Address
- No.1, Hongxiang Road, Kunming, China, 650500
- Phone
- 86 871 6818 5283
- Website
- hx8886.com
About Yunnan Hongxiang Yixintang
Yixintang Pharmaceutical Group Co., Ltd., together with its subsidiary, engages in the pharmaceutical retail chain and pharmaceutical distribution business. The company is involved in the wholesale, retail, leasing, and operation of medical devices; sale of food, disinfectants, disinfection equipment, and disposable medical products, household appliances, adult toys, agricultural and sideline products, cosmetics, and daily sundries and necessities; manufacturing of glasses; provision of value-added telecommunications, Internet live broadcast technology, and Internet information services for medicines, as well as clinic and foot bath services; operation of aquatic wild animals and call center; retail of publications; and decoction services for Chinese herbal medicines. It also engages in the agency sale of single-purpose commercial prepaid cards and China sports lottery; and maternal and child care activities. In addition, the company provides health care, housekeeping, amusement park, residents' daily life, and health consulting service, as well as business agency, ticket agency, personal Internet live broadcast, remote health management, corporate member points management, food delivery, and road freight transportation services. Further, it is involved in the import and export of goods and technology; wholesale of pet food and supplies; and wholesale of clothing and accessories. Additionally, the company sells products online. The company was formerly known as Yunnan Hongxiang Yixintang Pharmaceutical Co., Ltd. and changed its name to Yixintang Pharmaceutical Group Co., Ltd. in June 2019. Yixintang Pharmaceutical Group Co., Ltd. was founded in 2000 and is headquartered in Kunming, China.
Yunnan Hongxiang Yixintang management
6- Mr. Hong Xian RuanPresident & Executive Chairman · born 1966
- Mr. Yong ZhangExecutive President & Executive Director · born 1978
- Mr. Donglei XiaoFinancial Manager · born 1982
- Mr. Zheng Hong LiVP & Secretary · born 1986
- Mr. Guowei RuanVice President · born 1977
- Peng Juan YinAccounting Supervisor